These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26632316)

  • 1. Pre-exposure prophylaxis for South African adolescents: What evidence?
    Bekker LG; Gill K; Wallace M
    S Afr Med J; 2015 Nov; 105(11):907-11. PubMed ID: 26632316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women.
    Celum CL; Delany-Moretlwe S; McConnell M; van Rooyen H; Bekker LG; Kurth A; Bukusi E; Desmond C; Morton J; Baeten JM
    J Int AIDS Soc; 2015; 18(4 Suppl 3):20227. PubMed ID: 26198350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to Oral HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Pregnant and Post-partum Women from Cape Town, South Africa.
    Beesham I; Dovel K; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
    AIDS Behav; 2022 Sep; 26(9):3079-3087. PubMed ID: 35316471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "I am still negative": Female sex workers' perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa.
    Eakle R; Bothma R; Bourne A; Gumede S; Motsosi K; Rees H
    PLoS One; 2019; 14(4):e0212271. PubMed ID: 30964874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily Oral Pre-exposure Prophylaxis (PrEP) Continuation Among Women from Durban, South Africa, Who Initiated PrEP as Standard of Care for HIV Prevention in a Clinical Trial.
    Beesham I; Joseph Davey DL; Beksinska M; Bosman S; Smit J; Mansoor LE
    AIDS Behav; 2022 Aug; 26(8):2623-2631. PubMed ID: 35122575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-exposure prophylaxis as an opportunity for engagement in HIV prevention among South African adolescents.
    LoVette A; Kuo C; Giovenco D; Hoare J; Underhill K; Operario D
    SAHARA J; 2022 Dec; 19(1):1-7. PubMed ID: 35135437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review and Economic Analysis of the Dapivirine Vaginal Ring as HIV Pre-Exposure Prophylaxis for Women, to Inform South African Public-Sector Guidelines.
    Leong TD; Nel J; Jamieson L; Osih R; Dawood H; Subedar H; McCaul M; Johnson LF; Cohen K
    J Acquir Immune Defic Syndr; 2024 Nov; 97(3):261-272. PubMed ID: 39051791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV prevention is not all about HIV - using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection.
    Vickerman P; Quaife M; Kilbourne-Brook M; Mvundura M; Eakle R; Terris-Prestholt F
    BMC Infect Dis; 2020 Sep; 20(1):704. PubMed ID: 32977745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Oral Prep Interest Among South African Adolescents: The Role of Perceived Parental Support and PrEP Stigma.
    Giovenco D; Pettifor A; Bekker LG; Filiatreau LM; Liu T; Akande M; Gill K; Atujuna M; Stein DJ; Kuo C
    AIDS Behav; 2023 Jun; 27(6):1906-1913. PubMed ID: 36383273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.
    Smith DK; Van Handel M; Wolitski RJ; Stryker JE; Hall HI; Prejean J; Koenig LJ; Valleroy LA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1291-5. PubMed ID: 26606148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Missed Opportunities for Human Immunodeficiency Virus Pre-exposure Prophylaxis During Preventive Care and Reproductive Visits in Adolescents in the Deep South.
    Hill SV; Westfall AO; Coyne-Beasley T; Simpson T; Elopre L
    Sex Transm Dis; 2020 Feb; 47(2):88-95. PubMed ID: 31934955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing oral PrEP uptake among adolescent girls and young women in Africa.
    Heck CJ; Abdool Karim Q
    J Int AIDS Soc; 2022 Jan; 25(1):e25876. PubMed ID: 35048525
    [No Abstract]   [Full Text] [Related]  

  • 13. PrEP introduction for adolescent girls and young women.
    Mathur S; Pilgrim N; Pulerwitz J
    Lancet HIV; 2016 Sep; 3(9):e406-e408. PubMed ID: 27562739
    [No Abstract]   [Full Text] [Related]  

  • 14. Pills, Injections, Rings, or Implants? PrEP Formulation Preferences of PrEP-Experienced African Women for HIV Prevention.
    Ngure K; Mugo NR; Bukusi EA; Kiptinness C; Oware K; Gakuo S; Musinguzi N; Pyra M; Garrison L; Baeten JM; Haberer JE
    J Acquir Immune Defic Syndr; 2021 Dec; 88(4):e30-e32. PubMed ID: 34446676
    [No Abstract]   [Full Text] [Related]  

  • 15. Untangling the cost-effectiveness knot: who is oral antiretroviral HIV pre-exposure prophylaxis really for?
    Hankins CA
    Expert Rev Pharmacoecon Outcomes Res; 2014 Apr; 14(2):167-70. PubMed ID: 24552641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
    Verguet S; Stalcup M; Walsh JA
    Sex Transm Infect; 2013 Dec; 89(8):628-34. PubMed ID: 23912819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-exposure prophylaxis for human immunodeficiency virus: the past, present, and future.
    Castel AD; Magnus M; Greenberg AE
    Infect Dis Clin North Am; 2014 Dec; 28(4):563-83. PubMed ID: 25455314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection--New York, 2012-2015.
    Laufer FN; O'Connell DA; Feldman I; ; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1296-301. PubMed ID: 26606257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention.
    Karim QA; Archary D; Barré-Sinoussi F; Broliden K; Cabrera C; Chiodi F; Fidler SJ; Gengiah TN; Herrera C; Kharsany ABM; Liebenberg LJP; Mahomed S; Menu E; Moog C; Scarlatti G; Seddiki N; Sivro A; Cavarelli M
    Front Immunol; 2022; 13():1055042. PubMed ID: 36561760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How much could long-acting PrEP cost in South Africa?
    Mudimu E; Bershteyn A
    Lancet HIV; 2022 Dec; 9(12):e814-e815. PubMed ID: 36356602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.